Interestingly, evidence from mouse models of T-cell lymphoma suggests PD-1 may act as a tumor suppressor, providing a possible explanation for the hyperprogression seen in these trials [32]. The gene discussed is PDCD1; the disease is T-cell non-Hodgkin lymphoma.